Dr. Emerson Perin Leads DREAM-HF Trial – Demonstrating the Life-Saving Potential of Cell Therapy
Dr. Emerson C. Perin, Medical Director at The Texas Heart Institute, has been highlighted as the lead investigator in the...
All
The Texas Heart Institute and Baylor College of Medicine Announce Strategic Integration to Establish a Premier Cardiovascular Center
Houston, TX – (Nov. 21, 2024) – Baylor College of Medicine (Baylor) and The Texas Heart Institute (THI) have signed...
Dr. Jorge A. Miranda to Lead the Limb Preservation Clinic at The Texas Heart Institute Center for Cardiovascular Care
Jorge A. Miranda, MD, a highly skilled vascular surgeon with expertise in complex limb salvage procedures, is joining The Texas...
Championing Women’s Health: The Texas Heart Institute Hosts WomenHeart Advocates
The Texas Heart Institute (THI) has long been a champion of women’s cardiovascular health, dedicating over a decade to advancing...
Expanded Outpatient Practice Will Provide Personalized Comprehensive Cardiovascular Care for Patients with Cardiovascular Conditions
The Texas Heart Institute has expanded its outpatient practice with the addition of several specialized clinics, all housed in a...
ReVolutionary Heart Pump Offers New Hope for Infants with Congenital Heart Disease
A dedicated team of researchers and physicians are closer to realizing their hopes of a new device that will change...
World Menopause Day
Beyond Hot Flashes: The Impact of Menopause on Women’s Health Watch Dr. Coulter’s presentation on the impacts of menopause on...
October is Breast Cancer Awareness Month
The Texas Heart Institute Center for Cardiovascular Care is going PINK in support of, and raise awareness that October is Breast...
Dr. Nikolaos A. Diakos Awarded MacDonald Research Grant for Cardiogenic Shock Study
Dr. Nikolaos A. Diakos of The Texas Heart Institute has been awarded a Roderick D. MacDonald Research Fund grant to...
New Insights Into Heart Disease Risk for Houston Area Women
Houston HeartReach Study Examines Cardiometabolic Risk Factors for This Diverse Group Cardiovascular disease is the leading cause of death for...
7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...
Bringing Together the Best of Cardiovascular Science: The Texas Heart Institute Hosts 11th Annual IACS-NAS Meeting
Demonstrating its continued commitment to innovation in cardiovascular science and medicine, The Texas Heart Institute recently hosted the 11th Annual...
